Bausch Health Companies Inc. (BHCN.MX)

134.34 0.00 (0.00%) At close: 08:57AM CST

Bausch Health Companies Inc.

2150 St. ElzEar Boulevard West
Laval, QC H7L 4A8
Canada
514-744-6792
https://www.bauschhealth.com

Sector(s): Healthcare
Industry: Drugs - Generic
Full-time employees: 19,900

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Thomas J. Appio	CEO & Director	2.9M	N/A	1962
Mr. Thomas G. Vadaketh	Exec. VP & CFO	N/A	N/A	1963
Mr. Mirza Dautbegovic	Sr. VP & COO	N/A	N/A	N/A
Mr. John S. Barresi	Sr. VP, Controller & Chief Accounting Officer	N/A	N/A	1973
Dr. Robert F. Butz	VP of Medical & Scientific Affairs	N/A	N/A	N/A
Mr. Arthur J. Shannon	Sr. VP and Head of Investor Relations & Global Communications	N/A	N/A	N/A
Ms. Seana Carson	Exec. VP & Gen. Counsel	N/A	N/A	1972
Ms. Kathleen Fitzpatrick	Sr. VP & Chief HR Officer	N/A	N/A	N/A
Dr. Tage Ramakrishna M.D.	Chief Medical Officer and Pres of R&D	N/A	N/A	1974
Mr. Jeff Hartness	Sr. VP of Market Access, Commercial Operations & Gov. Affairs	N/A	N/A	N/A

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in MXN.

Description

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Latin America, Africa, and the Middle East. The Solta Medical segment offers medical devices. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic, dermatological, and dentistry products in the United States. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Corporate governance

Bausch Health Companies Inc.’s ISS governance QualityScore as of 1 March 2023 is 5. The pillar scores are Audit: 4; Board: 3; Shareholder rights: 3; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.